The overexpression of LDHA in non-small cell lung cancer (NSCLC) is primarily regulated by hypoxia-inducible factors (HIFs), which activate LDHA transcription under hypoxic conditions prevalent in tumours [106]. This evidence concerns the gene LDHA and non-small cell lung carcinoma.